Comerica Bank
ANIP icon

Comerica Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Comerica Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$691K Sell
8,754
-626
-7% -$54.2K ﹤0.01% 1714
2025
Q3 		$859K Sell
9,380
-2,086
-18% -$170K ﹤0.01% 1627
2025
Q2 		$748K Sell
11,466
-84
-0.7% -$5.47K ﹤0.01% 1674
2025
Q1 		$773K Sell
11,550
-7,280
-39% -$435K ﹤0.01% 1633
2024
Q4 		$1.04M Sell
18,830
-8,099
-30% -$465K ﹤0.01% 1511
2024
Q3 		$1.61M Buy
26,929
+3,366
+14% +$205K 0.01% 1264
2024
Q2 		$1.5M Sell
23,563
-13,100
-36% -$851K 0.01% 1271
2024
Q1 		$2.53M Sell
36,663
-192
-0.5% -$11.6K 0.01% 1062
2023
Q4 		$2.03M Buy
36,855
+1,626
+5% +$89.5K 0.01% 1149
2023
Q3 		$2.05M Buy
+35,229
New +$2.03M 0.01% 1069
2022
Q4 		$1.98M Sell
47,309
-643
-1% -$24.2K 0.02% 1088
2022
Q3 		$1.77M Buy
47,952
+36,767
+329% +$1.26M 0.01% 1133
2022
Q2 		$354K Sell
11,185
-10
-0.1% -$288 ﹤0.01% 1948
2022
Q1 		$367K Buy
11,195
+2,655
+31% +$99K ﹤0.01% 1971
2021
Q4 		$353K Buy
8,540
+178
+2% +$7.65K ﹤0.01% 1976
2021
Q3 		$308K Sell
8,362
-394
-4% -$12.2K ﹤0.01% 2046
2021
Q2 		$232K Sell
8,756
-547
-6% -$18.6K ﹤0.01% 2215
2021
Q1 		$307K Sell
9,303
-390
-4% -$12.2K ﹤0.01% 2140
2020
Q4 		$311K Buy
9,693
+66
+0.7% +$1.89K ﹤0.01% 2118
2020
Q3 		$279K Sell
9,627
-58
-0.6% -$1.73K ﹤0.01% 2097
2020
Q2 		$279K Buy
9,685
+698
+8% +$25K ﹤0.01% 2079
2020
Q1 		$375K Buy
8,987
+246
+3% +$13.1K ﹤0.01% 1864
2019
Q4 		$535K Buy
8,741
+23
+0.3% +$1.52K ﹤0.01% 1865
2019
Q3 		$677K Buy
8,718
+790
+10% +$59.1K 0.01% 1738
2019
Q2 		$641K Sell
7,928
-311
-4% -$22.1K 0.01% 1767
2019
Q1 		$570K Buy
8,239
+248
+3% +$14.6K ﹤0.01% 1836
2018
Q4 		$421K Sell
7,991
-74
-0.9% -$3.88K ﹤0.01% 1937
2018
Q3 		$449K Sell
8,065
-1,547
-16% -$94.7K ﹤0.01% 1934
2018
Q2 		$673K Buy
9,612
+292
+3% +$18.2K ﹤0.01% 1828
2018
Q1 		$565K Buy
9,320
+153
+2% +$9.71K ﹤0.01% 1861
2017
Q4 		$636K Sell
9,167
-240
-3% -$14.9K ﹤0.01% 1832
2017
Q3 		$551K Buy
9,407
+1,102
+13% +$52.5K ﹤0.01% 1865
2017
Q2 		$405K Sell
8,305
-550
-6% -$26.5K ﹤0.01% 1900
2017
Q1 		$486K Buy
8,855
+323
+4% +$18.1K ﹤0.01% 1875
2016
Q4 		$508K Buy
8,532
+451
+6% +$27.6K ﹤0.01% 1856
2016
Q3 		$553K Buy
8,081
+430
+6% +$26.9K ﹤0.01% 1744
2016
Q2 		$535K Sell
7,651
-172
-2% -$8.36K ﹤0.01% 1757
2016
Q1 		$338K Buy
7,823
+32
+0.4% +$1.08K ﹤0.01% 1869
2015
Q4 		$304K Buy
7,791
+149
+2% +$6.41K ﹤0.01% 1861
2015
Q3 		$302K Sell
7,642
-8,888
-54% -$506K ﹤0.01% 1876
2015
Q2 		$1.03M Buy
16,530
+8,496
+106% +$506K ﹤0.01% 1759
2015
Q1 		$503K Buy
+8,034
New +$489K ﹤0.01% 1760

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's ANIP Position: Q4 2025 in Review

Comerica Bank reduced its ANI Pharmaceuticals (ANIP) stake by 6.7% in Q4 2025, selling an estimated $54.2K and leaving 8,754 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #1714.

Comerica Bank first reported a position in ANIP in Q1 2015 and has held it in 42 quarters since. The position peaked at $2.53M in Q1 2024. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • Comerica Bank held 8,754 shares of ANI Pharmaceuticals worth $691K as of Q4 2025.
  • Comerica Bank sold 626 ANI Pharmaceuticals shares in Q4 2025, an estimated $54.2K.
  • ANI Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1714 holding.
  • Comerica Bank first reported a position in ANI Pharmaceuticals in Q1 2015 and has held it in 42 quarters since.
  • Comerica Bank's ANI Pharmaceuticals position peaked at $2.53M in Q1 2024.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.